News
Videos
Conferences
Events
Resources
Subscribe

|Articles|March 7, 2013

Being a “bad” patient

Author(s)Elizabeth Whittington

Newsletter

Stay up to date on cancer updates, research and education

Related Content

John Smelcer

Cancer in the Rearview Mirror

ByJohn Smelcer, PhD, CAGS

December 15th 2025

Image of two folks

Facing Lung Cancer Together: A Patient and Care Partner Share Their Journey

December 15th 2025

"FDA" text.

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

December 15th 2025

Image of Debbie.

Accepting That You Are Changed by Cancer

ByDebbie Legault

December 15th 2025

The FDA has granted breakthrough therapy designation to INCA033989 for some patients with essential thrombocythemi: © stock.adobe.com.

FDA Grants Breakthrough Designation to INCA-33989 in Essential Thrombocythemia

December 15th 2025

Trending on CURE

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

Light the Night and Survivorship: The Importance of Remembrance

Accepting That You Are Changed by Cancer

FDA Grants Breakthrough Designation to INCA-33989 in Essential Thrombocythemia

Spending the Holidays in Cancer Treatment

© 2025 MJH Life Sciences^®

All rights reserved.